Eur. J. Immunol. 2016Immunol. . 46: 2121Immunol. -2136 Introduction iNKT cells express a panoply of NK-cell receptors [1] and a canonical TCR through which they recognize (glyco-)lipid antigens [2] . iNKT cells activate similar signaling cascades after TCR ligation like other T lymphocytes [3] , but utilize unique transcription factors for their development such as the promyelocytic leukemia zinc finger (PLZF) [4] [5] [6] . According to two different developmental models PLZF characterizes distinct maturation stages and polarized subsets. The sequential lineage model suggests a gradual decrease of PLZFexpression following selection of iNKT cells which show a Th2-dominated cytokine profile during earlier and a Th1-dominated cytokine profile during later stages of intrathymic maturation [1, 7] . The second model describes lineage diversification and simultaneous differentiation into Th1-, Th2-, or Th17-polarized subsets that are defined by the level of PLZF-expression [8] . Although many iNKT cells release both Th1 and Th2 cytokines on a single cell level [9] , the production of IL-17 and IFN-γ is mutually exclusive within NK1.1 − cells [10] [11] [12] . Several transcription factors, such as Egr2, T-bet, ThPOK, Id2, Id3, and the Tec kinases Itk and Rlk have been implicated in the differentiation of iNKT cell subsets [6, 8, [13] [14] [15] [16] [17] which home to distinct tissues. Specifically, liver and spleen constitute the main source for the Th1-polarized sublineage which is PLZF low . Th2-or Th-17-polarized iNKT cells maintain their PLZF-expression at high or intermediate levels, respectively, and are primarily recovered from the lungs and peripheral lymph nodes [8, 12, 15] . Both subsets frequently express IL-17RB [18] and NP-1 which characterizes iNKT cells that recently emigrated from the thymus [19] . However, the role of NP-1 in iNKT cell biology has remained undefined. Although iNKT cells exhibit diverse functions, they still share molecules for tissue migration and adhesion. The chemokine receptor CXCR6 and the integrin LFA-1, for example, promote the accumulation of iNKT cells in the livers and lungs [20, 21] . While CXCR6 interacts with CXCL16, the heterodimeric integrins LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) interact with ICAM-1 [22] [23] [24] . Although an immune-suppressive role of CD11b + iNKT cells has been reported [25] , the regulation of CD11b-expression on iNKT cells is poorly understood. Furthermore, the mechanisms mediating the accumulation of iNKT cells at organ sites other than the liver and lung are unknown. TCR-specific signals influence the phenotype of iNKT cells [26] . One of the pivotal molecules engaged in TCR signaling is the adaptor protein Src homology (SH)2-domain-containing leukocyte phosphoprotein of 76 kDa (slp-76) [27, 28] . Due to impaired signals from the pre-TCR, T-cell development is completely blocked in slp-76 −/− mice [29] [30] [31] .
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The divergent functions of slp-76 are mediated by its distinct signaling domains. The N-terminal acidic domain contains three tyrosine phosphorylation sites [32] that are activated by ZAP-70 [33, 34] and subsequently bind to the guanine nucleotide exchange factor Vav [34] [35] [36] , the adaptor protein Nck [37, 38] , and the Tec-family kinase Itk [39, 40] . The central proline-rich domain of slp-76 interacts with PLCγ-1 [41] and the adaptor molecule GADS [42] . The C-terminal SH2 domain of slp-76 binds to the hematopoietic progenitor kinase HPK-1 [43] and to the adhesion and degranulation-promoting adaptor protein ADAP [44, 45] . While HPK-1 inhibits TCR signals [46] , ADAP is required for thymocyte selection and TCR-mediated integrinactivation/-expression [47] [48] [49] [50] .
Using 
Results iNKT cells from slp-76 ace/ace mice express less slp-76-and ADAP-protein
Whereas the N-terminal region of slp-76 is critical for T-cell selection [31] , the role of its C-terminal SH2 domain is less well understood. Therefore, we evaluated the phenotype of slp-76 ace/ace mice carrying a threonine to isoleucine amino acid change at position 428 within the SH2-domain of slp-76 (Thr428Ile) (52, 53) . In contrast to previously described mutations [33, 53, 54] , slp-76 ace/ace mice exhibited a reduced slp-76 protein expression in splenocyte lysates which was not rescued upon TCR-ligation (Fig. 1A) . Similar to NK and CD8 + T cells [52] , purified iNKT and CD4 + T cells from slp-76 ace/ace mice expressed significantly less slp-76 protein than their B6 counterparts (Fig. 1B, C) . In order to define the molecular pathways affected by the slp-76 mutation, we evaluated the expression of signaling molecules known to interact with slp-76 [27] Table 1 ). In contrast, IL-17RB, which is predominantly expressed on NKT2 and NKT17 cells [18] , was selectively reduced (Supporting Information Table 1 ). iNKT cells from 
Slp-76 requires ADAP for the regulation of LFA-1-and CD11b-, but not NP-1-expression
Although individual iNKT cell subsets exhibit diverse functions, they still share molecules for tissue migration and adhesion [20, 21, 64] . Thus, the iNKT cell phenotype in slp-76 ace/ace mice might result from an altered trafficking and/or homing rather than a developmental selection and/or polarization process. The distribution and level of CXCR6-, CXCR3-, CCL21-, and CCR7-expression were similar for B6 and slp-76 ace/ace iNKT cells (data not shown). In contrast, there was an organ-specific reduction of LFA-1-expression on slp-76 ace/ace iNKT cells (Fig. 5A ), particularly in the peripheral lymph nodes, but not in the liver, where LFA-1 had been implicated in the recruitment of iNKT cells [21, 64] . Thus, additional molecules might be involved in the organ distribution of iNKT cells. As both LFA-1 and CD11b bind to ICAM-1 [22, 24] and CD11b/ICAM-1 interactions promote the tissue adhesion of different cell populations [65] [66] [67] [68] , we also analyzed the expression of CD11b on iNKT cells. In contrast to conventional T cells [69] , peripheral iNKT cells were CD11b + already under steady-state conditions. CD11b-expression was significantly increased on iNKT cells from slp-76 ace/ace mice with the majority of CD11b + iNKT cells accumulating in the peripheral lymph nodes (Fig. 5B ). As ADAP interferes with different adhesion molecules [48] and as the expression of ADAP was reduced in slp-76 ace/ace iNKT cells ( data suggest that slp-76 requires ADAP for the regulation of LFA-1-und CD11b-expression on iNKT cells.
CD11b was most frequently expressed in the peripheral lymph nodes (Fig. 5B) , suggesting that iNKT cells with limited access to spleens and livers might be primarily redirected to this tissue site. Therefore, we assessed the distribution of additional markers on CD11b + iNKT cells. While there was no difference in the expression of CXCR6, CXCR3, CCL21, LFA-1, and CCR7, significantly more iNKT cells were NP-1 + in the peripheral lymph nodes of slp-76 ace/ace compared to B6 mice (Fig. 5E, F) suggesting an accumulation of recent iNKT cell thymic emigrants at this organ site [19] . As no differences in the expression of NP-1 were observed between ADAP −/− and control mice (data not shown), these data suggested that slp-76 is sufficient for the regulation of NP-1 on iNKT cells.
The reduced TCR signal strength is associated with an enhanced CD11b-expression
The slp-76 ace/ace mutation promotes the accumulation of PLZF low iNKT cells in the thymus (Fig. 3A) and of CD11b + iNKT cells in the periphery (Fig. 5B) . As altered TCR signals [31, [70] [71] [72] ] might contribute to this phenotype, we explored the regulation of the TCR-specific immediate early gene Nr4a1/Nur77 [31, 73] , which has been used as readout for TCR signaling strength [74] . To this end, we crossed slp-76 ace/ace with Nur77 GFP mice, in which GFP is expressed in T cells after TCR-specific engagement [74] . In accordance with both developmental models (see introduction), the brightest expression of Nur77 was reported in PLZF high iNKT cells in the thymus, whereas GFP-expression was lost upon thymic emigration so that iNKT cells remained Nur77-GFP − in the periphery [8, 74] . Compared to their B6 counterparts iNKT cells from the thymi of slp76 ace/ace mice exhibited an overall reduced GFPexpression (data not shown). This difference was most prominent within the PLZF high and PLZF int populations (Supporting Information Fig. 3A) . Accordingly, the GFP signal in splenic iNKT cells on the Nur77 GFP x slp-76 ace/ace background was attenuated upon stimulation with α-GalCer (Fig. 5G) . Furthermore, the expression of PD-1 that transduces inhibitory signals [75] and correlates with the strength of TCR signaling [74] , was significantly reduced on iNKT cells within all tissue sites of slp-76 ace/ace mice (Supporting Information Fig. 3B ).
To test, whether the TCR signal strength affects the expression of integrins, we compared the distribution of CD11b, LFA-1, and NP-1 on iNKT cells with respect to their Nur77-expres-sion. TCR ligation enhanced the expression of CD11b, LFA-1, and NP-1 + αGalCer-tetramer + cells (see Fig. 2A ) in the spleens. Representative FACS plots for the release of IFN-γ by NKT cells are displayed (E, G). Statistical significant differences were determined using a Student's t-test. A p-value <0.5 (*) or <0.01 (**) was considered significant. ace/ace xNur77 GFP mice injected 6 h before with 1 μg α-GalCer. Data are shown as mean ±SD and are representative of two independent experiments. Statistical significant differences were determined using a Student's t-test. A p-value <0.5 (*), <0.01 (**) or <0.001 (***) was considered significant.
( Fig. 5H; data iNKT cells.
CD11b inhibits the accumulation of iNKT cells in the liver and the release of cytokines
To evaluate the function of CD11b on iNKT cells, we analyzed CD11b −/− and control mice. We recovered two times more iNKT cells from the livers of CD11b −/− compared to B6 mice (Fig. 6A ).
The expression of LFA-1 and of NP-1 was comparable on B6 and −/− mice were divided into PLZF high -, PLZF int -, and PLZF low -expressing subsets and the relative distribution of the three subsets was summarized for the indicated organs. Data are shown as mean ±SD and are representative of three independent experiments. Statistical significant differences were determined using a Student's t-test. A p-value <0.5 (*) was considered significant.
CD11b
−/− iNKT cells (Fig. 6B, C) , indicating that CD11b does not directly interfere with the expression of the other two integrins regulated by the slp-76 mutation.
As the reduced induction of the TCR immediate early gene Nur77 and the decreased cytokine production of iNKT cells from slp -76 ace/ace mice upon TCR ligation was paralleled by an enhanced CD11b-expression, we explored the release of cytokines in splenocyte cultures from CD11b −/− and B6 mice, in which comparable numbers of iNKT cells were detected (Fig. 6A) . The application of α-GalCer induced a significantly enhanced cytokine release in CD11b −/-mice (Fig. 6D, E) without affecting the polarization of iNKT cells or their PLZF-expression (Fig. 6F) . In addition, significantly more IFN-γ + iNKT cells were detected in CD11b −/− compared to B6 mice (13.43% ± 3.71 versus 9.91% ± 2.38; p<0.05; data are mean ±SD of two experiments with a total of 6 mice upon PMA/ionomycin stimulation of splenocyte cultures).
CD11b-deficiency exacerbates hepatic inflammation
iNKT cells play a pivotal role in the induction of liver damage [2] . Thus, we evaluated the impact of CD11b on ConA-induced hepatitis. CD11b −/-mice exhibited a significantly enhanced liver damage compared to littermate controls (Fig. 7A, B) , similar as observed in a poly IC-induced liver damage model [76] . To elucidate the role of CD11b on iNKT cells, we reconstituted irradiated Ly5. (Fig. 5B) , ConA-induced hepatitis was ameliorated in slp-76 ace/ace mice compared to B6 controls (Fig. 7D) .
Thus, the loss of function mutation within slp-76 is associated with an enhanced expression of CD11b on iNKT cells, which inhibits the induction of immediate early genes, the release of cytokines, iNKT cell accumulation and liver inflammation.
ICAM-1 binds preferably to LFA-1
+ iNKT cells LFA-1 binds better to ICAM-1 than to CD11b on neutrophils [77] . To evaluate whether similar mechanisms apply for iNKT cells, we exposed liver MNCs enriched for iNKT cells from B6 and slp-76 ace/ace mice to plate bound ICAM-1. Significantly more B6 than slp-76 ace/ace iNKT cells adhered to ICAM-1 (Fig. 8A) . To evaluate the contribution of LFA-1 and CD11b on the adhesion capacity of iNKT cells, we blocked both integrins by antibodies. Similar to neutrophils, only the blockade of LFA-1 significantly reduced the number of iNKT cells bound to ICAM-1 (Fig. 8B) Fig. 8C and D) , the blockade of VEGF had no effect (data not shown). Furthermore, none of the two antibodies affected the production of cytokines upon stimulation with α-GalCer in either mouse strain ( Fig. 8E and F ; data not shown). Thus, these data identify NP-1 as critical molecule for the accumulation of iNKT cells within peripheral lymph nodes.
Discussion
In this study we report a role of slp-76 for the regulation of PLZFexpression and the tissue distribution of iNKT cells. Despite the accumulation of PLZF low iNKT cells in the thymi of slp-76 ace/ace mice and an enhanced expression of different NK-cell receptors, iNKT cells were not Th1-polarized and even strikingly reduced in spleens and livers, organ sites in which PLZF low , Th1-polarized [8] iNKT cells are usually abundantly detected [15] . Instead, iNKT cells accumulated in the peripheral lymph nodes and the thymi of slp-76 ace/ace mice and were hyporeactive following TCR ligation, resulting in an overall reduced cytokine release and inability to induce tissue inflammation. Slp-76 ace/ace iNKT cells showed a significantly decreased expression of ADAP, the primary interaction partner for the SH2 domain of slp-76 [78] . The strikingly reduced accumulation of iNKT cells in livers and spleens was paralleled by an extenuated LFA-1-and enhanced CD11b-expression in both ADAP −/− and slp-76 ace/ace mice. These findings support the concept that ADAP is pivotal for the transmission of slp-76-mediated signals. As iNKT cells with a slp-76 ace/ace mutation or a ADAP-deletion exhibited no differences in the expression of apoptotic or proliferation markers compared to control mice (data not shown) and as the expression of CD1d or ICAM-1 on myeloid cells was not affected in both mouse strains either, we concluded that the inverse regulation of CD11b-with LFA-1-expression by slp-76-ADAP interactions inhibited the accumulation of iNKT cells in the liver due to an altered competition of CD11b with LFA-1 for their common ligand ICAM-1 [79] . Thus, iNKT cells, which failed to adhere to ICAM-1 + cells in the liver, frequently expressed CD11b and were redistributed to the peripheral lymph nodes due to an enhanced simultaneous NP-1-expression. Although slp-76-ADAP interactions controlled the accumulation of iNKT cells in the spleen, the participating chemokine(s) and/or adhesion factor(s) still need to be identified. In contrast to CD11b and LFA-1, slp-76 ADAP-independently regulated the expression of NP-1, a transmembrane glycoprotein, which binds to VEGF receptors and exhibits various functions, many of them yet to be defined [80] [81] [82] [83] . Here, we identified NP-1 as critical molecule for the accumulation of iNKT cells in peripheral lymph nodes. As only the application of anti-NP-1-antibodies, As the expression of PLZF and of Id3 [63] , however, was reduced in iNKT cells from slp-76 ace/ace compared to B6 mice, our data suggest that slp-76 regulates Id3 and PLZF ADAP-independently. The reduced expression of Id3, which has been described as suppressor of iNKT cell expansion in the thymus [17] , probably contributes to the thymic accumulation of iNKT cells in slp-76 ace/ace mice. In contrast, the contribution of chemokines and/or integrins might be only subsidiary. Accordingly we did not detect any variations in the expression of CXCR3 (data not shown), which has been described as critical for the retention of iNKT cells in the thymus [84] . In summary, we show that a loss of function mutation within the SH2 domain of slp-76 promotes the accumulation of PLZF low iNKT cells in the thymus and a striking redistribution of iNKT cells from the livers and spleens to the peripheral lymph nodes. While ADAP was not required for the accumulation of iNKT cells in the thymus and the peripheral lymph nodes or the regulation of NP-1-, PLZF-, and Id3-expression, it was pivotal for the inverse expression of LFA-1 and CD11b by slp-76 and the inhibition of iNKT cell accumulation in the livers. Despite an enhanced expression of different NK cell receptors, suggesting an increased Th1-polarization according to published models of iNKT cell differentiation [1, 7, 8] , we discovered a simultaneous reduction of both IL-4-and IFN-γ-expression by CD11b
+ iNKT cells and an overall reduced TCR-reactivity in iNKT cells from mice carrying the slp-76 ace/ace -mutation. Thus, variations in the tissue distribution rather than the cytokine polarization need to be considered in patients with allelic mutations in TCR signaling molecules before pursuing vaccination strategies involving α-GalCer as an adjuvant.
Materials and methods

Mice
All mice were bred and kept at the University of Erlangen (Erlangen, Germany) and at Cincinnati Children´s Hospital (Cincinnati, OH, USA). Slp-76 ace/ace mice with a threonine to isoleucine amino acid change at position 428 were recently described [51, 52] were from the Jackson Laboratory (Bar Harbor, ME, USA). All mice were raised in a specific pathogen-free environment and used at the age of 6-8 weeks. The animal studies were conducted according to the Institutional and Governmental Animal Care and Use Guidelines.
ConA hepatitis
ConA (Sigma) was dissolved in sterile PBS and injected intravenously in a final volume of 100 μL at a dose of 25 mg/kg. CD11b −/-and B6 mice were euthanized for the collection of blood and livers 12 h later. Biochemical as well as histopathological analyses from the plasma (ALT, AST) and tissues (H&E staining) were performed.
Blocking antibody experiments
Blocking antibodies against mouse CD11a (LFA-1; M17/4), CD54 (ICAM-1; YNI.7.4), CD11b (Mac-1; M1/70) and rat IgG2a Control (2A3) or NP-1 (761704) were obtained from BioXCell or R&D Systems. Two hundred micrograms isotype control, 100 μg anti-LFA-1, 200 μg anti-ICAM-1 or 200 μg anti-CD11b antibodies were injected intravenously 3 h before the harvest of the respective tissues. Anti-NP-1 was injected intraperitoneally every other day (10 mg/kg body weight) for 8 days.
Bone marrow chimeras
For the preparation of bone marrow radiation chimeras, a 1:4 mixture of 2 × 10 6 CD11b −/− or B6 and 8 × 10 6 Jα18 −/− bone marrow cells was injected intravenously into 7-12 weeks-old Ly5.1 mice which had been irradiated twice within a 4-h interval (first 500 Rad, then 400 Rad; Gamma Cell 2000, Molsgaard Dental A/S, Copenhagen, Denmark) one day prior to the transfer. The reconstitution of mixed bone marrow chimeras was analyzed by flow cytometry 6-8 weeks after the bone marrow injection.
Flow cytometry
Single cell suspensions were prepared by gently passing the respective organs through 70 μm pore size cell strainers (Corning Incorporated, Corning, NY, USA). Liver homogenates were further purified by density gradient centrifugation using a Bicoll solution with a density of 1077 g/mL (Biochrom, Berlin, Germany). Single cell suspensions were stained with antibodies purchased from eBioscience (San Diego, CA, USA) or R&D Systems (Minneapolis, MN, USA): anti-mouse TCRβ-APCeFluor780, CD45.1-PE-Cyanine7, CD45.1-FITC, CD45.2-FITC, CD45.2-PerCPCyanine5.5, CD11b-PE-Cyanine7, CD11b-FITC, CD11b-PerCPCyanine5.5, CD11a-PerCP-eFluor710, RORγt-PerCP-eFluor710, PLZF-PE, IFN-γ-PE, T-bet-PerCP-Cyanine5.5, NK1.1-PE, CD122-PE, IL-17RB-APC, NKG2D-PE-Cyanine7, CD1d-PE, Ly49G2-FITC, Neuropilin-1(CD304)-FITC, gamma-delta TCR-PerCPCyanine5.5, PD-1(CD279)-PerCP-Cyanine5.5, CD54(ICAM-1)-PE, B220(CD45R)-PE-Cyanine7, FoxP3-PE and CD11c-APCeFluor780. α-GalCer-loaded CD1d-tetramers were obtained from the NIH Tetramer Core Facility (Emory University Vaccine Center, Atlanta, GA, USA). Fixation and permeabilization of cells for intracellular staining of PLZF, FoxP3, T-bet and IFN-γ were performed using the FoxP3 staining Kit from eBioscience (San Diego, CA, USA). Cells were measured on a FACS Canto II (BD Biosciences, Franklin Lakes, NJ, USA) and analyzed with FlowJo software (Ashland, OR, USA).
Purification of iNKT cells
The single cell suspensions were pre-sorted for CD8-and CD19-negativity with MACS Microbead Technology (Miltenyi Biotec, Bergisch Gladbach, Germany), subsequently stained with anti-TCRβ mAb and CD1d tetramer and sorted on a FACS Aria II (BD Biosciences, Franklin Lakes, NJ, USA).
In vitro stimulation of iNKT cells
Spleen cell suspensions were incubated in round-bottom plates in RPMI1640 medium supplemented with glutamine, antibiotics, and 10% FCS (Sigma Aldrich, St. Louis, MO, USA) with 50 ng/mL plate-bound anti-CD3 antibody (eBioscience, San Diego, CA, USA), PMA/Ionomycin (Cell Stimulation Cocktail, eBioscience, San Diego, CA, USA), 0.1-100 ng/mL α-GalCer [85] or an equivalent amount of DMSO (Carl Roth, Karlsruhe, Germany). CD11b-and Nur77-GFP-expression on as well as IFN-γ-and T-betexpression in iNKT cells were analyzed using FACS. Cytokines in the cell culture supernatants were measured using the respective DuoSet ELISAs from R&D Systems (Minneapolis, MN, USA) following the manufacturer's instructions.
Cell adhesion assay
The 96-well round bottom plates were pre-coated over night with 10 μg/mL ICAM-1 (Sino Biol. Inc., China) in a 10% BSA solution. 5 × 10 5 liver mononuclear cells (MNCs) enriched for iNKT cells by CD8 and CD19 depletion were added to the pre-coated wells.
To some cultures blocking antibodies to CD11b (clone M1/70; eBioscience) and LFA-1 (clone M 17/4; eBioscience) were added at a concentration of 20 μg/mL. After incubation at 37°C in 5% CO 2 for 3 h, non-adherent cells were removed by washing three times with PBS. Adherent cells were scraped off and collected as well. Both, adherent and non-adherent cells were stained separately with anti-TCRβ mAb and CD1d tetramer. The percentages and total numbers of adherent and non-adherent iNKT cells were estimated by flow cytometry and compared to the original number of iNKT cells seeded in the respective chambers.
Western blotting
In vitro stimulated splenocytes, purified CD4-positive T cells or iNKT cells were lysed with cell lysis buffer (Cell Signaling Technology, Danvers, MA, USA) containing a protease inhibitor cocktail (Roche, Indianapolis, IN, USA) according to manufacturer's instructions. Cell lysates were subjected to SDS-PAGE and transferred to PVDF-membranes (Merck Millipore, Darmstadt, Germany). Membranes were blocked with 5% milk powder in TBS with 0.05% Tween (Sigma Aldrich, St. Louis, MO, USA) and subsequently incubated with primary and secondary antibodies. The primary antibodies against mouse slp-76, ADAP, HPK-1, GAPDH, 
